GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $26,631,000 | +120.6% | 391,051 | +3.5% | 0.02% | +130.0% |
Q2 2022 | $12,073,000 | -1.1% | 377,862 | +7.2% | 0.01% | +25.0% |
Q1 2022 | $12,204,000 | +17.9% | 352,335 | -0.4% | 0.01% | +14.3% |
Q4 2021 | $10,354,000 | +18.8% | 353,745 | +3.4% | 0.01% | +16.7% |
Q3 2021 | $8,715,000 | -27.3% | 342,025 | -0.1% | 0.01% | -25.0% |
Q2 2021 | $11,989,000 | +41.7% | 342,356 | +64.9% | 0.01% | +33.3% |
Q1 2021 | $8,463,000 | +52.9% | 207,672 | +62.5% | 0.01% | +50.0% |
Q4 2020 | $5,534,000 | +17.6% | 127,785 | +49.8% | 0.00% | 0.0% |
Q3 2020 | $4,705,000 | -21.1% | 85,326 | -9.7% | 0.00% | -33.3% |
Q2 2020 | $5,964,000 | +15.8% | 94,467 | -6.3% | 0.01% | 0.0% |
Q1 2020 | $5,152,000 | -38.9% | 100,834 | -4.9% | 0.01% | -25.0% |
Q4 2019 | $8,429,000 | +166.0% | 106,033 | +62.3% | 0.01% | +166.7% |
Q3 2019 | $3,169,000 | -2.0% | 65,318 | +6.3% | 0.00% | 0.0% |
Q2 2019 | $3,233,000 | +29.5% | 61,472 | +30.3% | 0.00% | 0.0% |
Q1 2019 | $2,497,000 | +8.8% | 47,179 | -15.7% | 0.00% | 0.0% |
Q4 2018 | $2,296,000 | +2.6% | 55,941 | -5.0% | 0.00% | +50.0% |
Q3 2018 | $2,238,000 | -16.5% | 58,882 | -0.7% | 0.00% | -33.3% |
Q2 2018 | $2,680,000 | – | 59,301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |